Nexus Nutri Science Profile
Key Indicators
- Authorised Capital ₹ 1.25 Cr
as on 17-11-2024
- Paid Up Capital ₹ 1.25 Cr
as on 17-11-2024
- Company Age 5 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 6.70 Cr
as on 17-11-2024
- Satisfied Charges ₹ 3.42 Cr
as on 17-11-2024
- Revenue 63.52%
(FY 2023)
- Profit 71.55%
(FY 2023)
- Ebitda 7.24%
(FY 2023)
- Net Worth 100.28%
(FY 2023)
- Total Assets -15.15%
(FY 2023)
About Nexus Nutri Science
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.25 Cr and a paid-up capital of Rs 1.25 Cr.
The company currently has active open charges totaling ₹6.70 Cr. The company has closed loans amounting to ₹3.42 Cr, as per Ministry of Corporate Affairs (MCA) records.
Manojkumar Suvagiya, Chirag Bhanderi, and Ashokbhai Gajera serve as directors at the Company.
- CIN/LLPIN
U24304GJ2019PLC107049
- Company No.
107049
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
13 Mar 2019
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Nexus Nutri Science?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Manojkumar Suvagiya  | Director | 13-Mar-2019 | Current |
| Chirag Bhanderi | Director | 13-Mar-2019 | Current |
| Ashokbhai Gajera | Director | 13-Mar-2019 | Current |
Financial Performance of Nexus Nutri Science.
Nexus Nutri Science Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 63.52% increase. The company also saw a substantial improvement in profitability, with a 71.55% increase in profit. The company's net worth Soared by an impressive increase of 100.28%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Nexus Nutri Science?
In 2022, Nexus Nutri Science had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 13 Sep 2023 | ₹9.53 M | Open |
Others Creation Date: 26 Jul 2023 | ₹5.00 Cr | Open |
Others Creation Date: 26 Jul 2023 | ₹7.47 M | Open |
How Many Employees Work at Nexus Nutri Science?
Unlock and access historical data on people associated with Nexus Nutri Science, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nexus Nutri Science, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nexus Nutri Science's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
